Matrixyl
Palmitoyl pentapeptide-4, pal-KTTKS, Matrixyl 3000
A collagen fragment with a fatty acid bolted on so it can cross skin, and one of the few cosmetic peptides with a randomised trial behind it.
Human trials
A cosmetic ingredient requiring no premarket approval in the United States, and not permitted to carry drug claims. Not an approved drug.
What it is
KTTKS is a five amino acid sequence from type I procollagen. When collagen breaks down, fragments like this are released, and the skin reads them as a signal that repair is needed and increases matrix synthesis.
Matrixyl is that pentapeptide with palmitic acid attached. The fatty acid is the entire innovation: it makes an otherwise hydrophilic peptide lipophilic enough to partition into the stratum corneum. Without it, KTTKS sits on the surface.
That is a more credible delivery story than Argireline has, because the target is in the dermis rather than in a muscle beneath it, and because the modification was made specifically to solve the absorption problem.
What the evidence shows
Better than most of this category, which is a low bar cleared honestly.
A double-blind randomised trial compared palmitoyl pentapeptide-4 cream against acetylhexapeptide-3 cream for crow's feet and found measurable improvement in wrinkle appearance. Earlier work on pal-KTTKS reported improvements in fine lines and wrinkle depth against vehicle over twelve weeks. Separate studies have looked at wound healing applications and at whether delivery format changes the result.
The effect sizes are small. They are also measured against vehicle in blinded designs, which is more than can be said for most ingredients in a serum.
How to read a cosmetic peptide claim
Three things separate the defensible claims from the rest, and this ingredient satisfies more of them than most.
The peptide needs a plausible route into the skin, which the palmitoyl modification provides. The target needs to be reachable by that route, and dermal fibroblasts are. And the study needs a vehicle control, because moisturiser alone improves the appearance of fine lines and any comparison against untreated skin measures hydration rather than the active.
Argireline fails the first two and has reasonable studies. Matrixyl satisfies all three and has small effects. That combination is what an honest cosmetic ingredient usually looks like.
Practical notes
- Twelve weeks is the minimum honest assessment window. Collagen synthesis is slow. Anything visible in a week is hydration, which is fine and is not what this ingredient claims.
- Matrixyl 3000 and Matrixyl synthe-6 are different products. They contain different peptides under a shared brand, and the studies do not transfer between them.
- Retinoids remain the better-evidenced option. Tretinoin has decades of randomised trials for photoaging with effect sizes no peptide approaches. Matrixyl is a reasonable addition, not a replacement.
Side effects and warning signs
Commonly reported
- Local irritation, uncommon
- Very well tolerated across studies
Stop and get medical help
- No meaningful systemic risk. The realistic failure mode is a product that does less than claimed, not one that causes harm
Sources
From the community
Discussion for this compound concentrates in r/SkincareAddiction.
No threads cached yet.
Reddit removed unauthenticated API access, so this section is populated by a build-time script using your own API credentials. Run pnpm fetch:reddit with REDDIT_CLIENT_ID and REDDIT_CLIENT_SECRET set.